Natasha Bayliss
About Natasha Bayliss
Natasha Bayliss is a Senior Scientist at KalVista Pharmaceuticals, Inc., with a background in toxicology and pharmacology. She has over a decade of experience in scientific roles, including positions at The Institute of Cancer Research and Huntingdon Life Sciences.
Work at KalVista Pharmaceuticals
Natasha Bayliss has been employed at KalVista Pharmaceuticals, Inc. as a Senior Scientist since 2018. In this role, she contributes to the company's research and development efforts, focusing on innovative solutions in the pharmaceutical field. Her expertise in toxicology and pharmacology supports the advancement of KalVista's projects.
Previous Experience at The Institute of Cancer Research
Prior to her current position, Natasha Bayliss worked at The Institute of Cancer Research as a Higher Scientific Officer from 2008 to 2017. During her nine years there, she engaged in various research initiatives aimed at understanding cancer biology and developing therapeutic strategies.
Background in Forensic Science
Natasha Bayliss began her career as a DNA Analyst at the Forensic Science Service in Birmingham, United Kingdom, from 2005 to 2006. This role involved analyzing DNA samples and contributing to forensic investigations, providing her with a strong foundation in analytical techniques.
Education and Expertise in Toxicology and Pharmacology
Natasha Bayliss holds a Master of Science in Toxicology from The University of Birmingham, which she completed in 2004. She also earned a Bachelor of Science in Pharmacology from The University of Sheffield in 2002. Her educational background equips her with a comprehensive understanding of drug development and safety assessment.
Experience at Huntingdon Life Sciences
From 2006 to 2008, Natasha Bayliss served as a Senior Study Analyst (Pharmacokinetics) at Huntingdon Life Sciences. In this position, she focused on the pharmacokinetic evaluation of compounds, contributing to preclinical studies and enhancing her expertise in drug metabolism and pharmacokinetics.